skip to main content
Idioma:
Refinado por: autor: Herbst, Regina remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial

Platzbecker, Uwe ; Middeke, Jan Moritz ; Sockel, Katja ; Herbst, Regina ; Wolf, Dominik ; Baldus, Claudia D ; Oelschlägel, Uta ; Mütherig, Anke ; Fransecky, Lars ; Noppeney, Richard ; Bug, Gesine ; Götze, Katharina S ; Krämer, Alwin ; Bochtler, Tilmann ; Stelljes, Matthias ; Groth, Christoph ; Schubert, Antje ; Mende, Marika ; Stölzel, Friedrich ; Borkmann, Christine ; Kubasch, Anne Sophie ; von Bonin, Malte ; Serve, Hubert ; Hänel, Mathias ; Dührsen, Ulrich ; Schetelig, Johannes ; Röllig, Christoph ; Kramer, Michael ; Ehninger, Gerhard ; Bornhäuser, Martin ; Thiede, Christian

The lancet oncology, 2018-12, Vol.19 (12), p.1668-1679 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?

Röllig, Christoph ; Kramer, Michael ; Schliemann, Christoph ; Mikesch, Jan-Henrik ; Steffen, Björn ; Krämer, Alwin ; Noppeney, Richard ; Schäfer-Eckart, Kerstin ; Krause, Stefan W. ; Hänel, Mathias ; Herbst, Regina ; Kunzmann, Volker ; Einsele, Hermann ; Jost, Edgar ; Brümmendorf, Tim H. ; Scholl, Sebastian ; Hochhaus, Andreas ; Neubauer, Andreas ; Sohlbach, Kristina ; Fransecky, Lars ; Kaufmann, Martin ; Niemann, Dirk ; Schaich, Markus ; Frickhofen, Norbert ; Kiani, Alexander ; Heits, Frank ; Krümpelmann, Ulrich ; Kaiser, Ulrich ; Kullmer, Johannes ; Wass, Maxi ; Stölzel, Friedrich ; von Bonin, Malte ; Middeke, Jan Moritz ; Thiede, Christian ; Schetelig, Johannes ; Berdel, Wolfgang E. ; Ehninger, Gerhard ; Baldus, Claudia D. ; Müller-Tidow, Carsten ; Platzbecker, Uwe ; Serve, Hubert ; Bornhäuser, Martin

Blood, 2020-08, Vol.136 (7), p.823-830 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia
Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Röllig, Christoph ; Kramer, Michael ; Schliemann, Christoph ; Mikesch, Jan-Henrik ; Steffen, Björn ; Krämer, Alwin ; Sauer, Tim ; Hänel, Mathias ; Herbst, Regina ; Schäfer-Eckart, Kerstin ; Noppeney, Richard ; Jost, Edgar ; Brümmendorf, Tim H ; Krause, Stefan W ; Kunzmann, Volker ; Einsele, Hermann ; Scholl, Sebastian ; Hochhaus, Andreas ; Fransecky, Lars R. ; Kaufmann, Martin ; Neubauer, Andreas ; Niemann, Dirk ; Schaich, Markus ; Frickhofen, Norbert ; Kiani, Alexander ; Heits, Frank ; Krümpelmann, Ulrich ; Kaiser, Ulrich ; Kullmer, Johannes ; Wass, Maxi ; Klein, Stefan ; Von Bonin, Malte ; Middeke, Jan Moritz ; Thiede, Christian ; Stoelzel, Friedrich ; Schetelig, Johannes ; Ehninger, Gerhard ; Baldus, Claudia D ; Müller-Tidow, Carsten ; Platzbecker, Uwe ; Serve, Hubert ; Bornhäuser, Martin

Blood, 2019-11, Vol.134 (Supplement_1), p.13-13 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
4
Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial
Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of Genetic Abnormalities and Measurable Residual Disease Levels on Outcome in Patients with MDS/AML Pre-Emptively Treated with Azacitidine: Correlative Results of the Prospective RELAZA2 Trial

Kayser, Sabine ; Middeke, Jan Moritz ; Kramer, Michael ; Sockel, Katja ; Stasik, Sebastian ; Herbst, Regina ; Fransecky, Lars R. ; Wolf, Dominik ; Martin, Schumacher ; Krämer, Alwin ; Noppeney, Richard ; Novotny, Juergen ; Bug, Gesine ; Götze, Katharina S. ; Spiekermann, Karsten ; Stelljes, Matthias ; Mikesch, Jan-Henrik ; Subklewe, Marion ; Schubert, Antje ; Mütherig, Anke ; Bochtler, Tilmann ; Mende, Marika ; Stoelzel, Friedrich ; Kubasch, Anne ; Von Bonin, Malte ; Haenel, Mathias ; Duehrsen, Ulrich ; Schetelig, Johannes ; Rollig, Christoph ; Baldus, Claudia D ; Ehninger, Gerhard ; Müller-Tidow, Carsten ; Serve, Hubert ; Bornhäuser, Martin ; Platzbecker, Uwe ; Thiede, Christian

Blood, 2020-11, Vol.136 (Supplement 1), p.10-11 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia
Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Middeke, Jan Moritz ; Rollig, Christoph ; Kramer, Michael ; Kramer, Alwin ; Bochtler, Tilman ; Scholl, Sebastian ; Hochhaus, Andreas ; Jost, Edgar ; Brümmendorf, Tim H. ; Naumann, Ralph ; Steffen, Björn ; Kunzmann, Volker ; Einsele, Hermann ; Schaich, Markus ; Burchert, Andreas ; Neubauer, Andreas ; Schäfer-Eckart, Kerstin ; Schliemann, Christoph ; Krause, Stefan W ; Herbst, Regina ; Hänel, Mathias ; Frickhofen, Norbert ; Noppeney, Richard ; Kaiser, Ulrich ; Baldus, Claudia D. ; Kaufmann, Martin ; Racil, Zdenek ; Stasik, Sebastian ; Sockel, Katja ; von Bonin, Malte ; Müller-Tidow, Carsten ; Platzbecker, Uwe ; Berdel, Wolfgang E. ; Mayer, Jiri ; Serve, Hubert ; Ehninger, Gerhard ; Schetelig, Johannes ; Thiede, Christian ; Stoelzel, Friedrich

Blood, 2018-11, Vol.132 (Supplement 1), p.1461-1461 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
6
The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial
The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Rollig, Christoph ; Serve, Hubert ; Hüttmann, Andreas ; Noppeney, Richard ; Müller-Tidow, Carsten ; Krug, Utz ; Baldus, Claudia D. ; Brandts, Christian H. ; Kunzmann, Volker ; Einsele, Hermann ; Krämer, Alwin ; Schäfer-Eckart, Kerstin ; Neubauer, Andreas ; Burchert, Andreas ; Giagounidis, Aristoteles ; Krause, Stefan W. ; Mackensen, Andreas ; Aulitzky, Walter E. ; Herbst, Regina ; Hänel, Mathias ; Kiani, Alexander ; Frickhofen, Norbert ; Kullmer, Johannes ; Kaiser, Ulrich ; Link, Hartmut ; Geer, Thomas ; Reichle, Albrecht ; Junghanss, Christian ; Repp, Roland ; Heits, Frank ; Durk, Heinz Albert ; Illmer, Thomas ; Bornhäuser, Martin ; Schaich, Markus ; Parmentier, Stefani Barbara ; Goerner, Martin ; Thiede, Christian ; von Bonin, Malte ; Schetelig, Johannes ; Kramer, Michael ; Berdel, Wolfgang E. ; Ehninger, Gerhard

Blood, 2017-12, Vol.130 (Suppl_1), p.721-721 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.